You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

statin, hemodialysis

Showing 1 - 25 of 2,917
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease Trial in Busan (Pitavastatin, Atorvastatin)

Completed
  • Chronic Kidney Disease
  • Busan, Korea, Republic of
  • +1 more
Sep 18, 2021

Covid19 Trial in Tehran (intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/

Completed
  • Covid19
  • intermediate dose Enoxaparin/ unfractionated heparin
  • +3 more
  • Tehran, Iran, Islamic Republic of
    Masih Daneshvari Hospital
Aug 14, 2021

Drug Adherence Trial (Red yeast rice extract initial therapy followed later on by statin therapy, Statin therapy)

Not yet recruiting
  • Moderate 10-year Atherosclerotic Cardiovascular Disease Risk Patients
  • Red yeast rice extract initial therapy followed later on by statin therapy
  • Statin therapy
  • (no location specified)
Apr 26, 2023

Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

Recruiting
  • Hypercholesterolemia
  • K-877 0.2 mg/day (once daily)
  • +2 more
  • Aichi, Japan
  • +14 more
Jun 20, 2023

Physical Activity Levels and Statin Therapy

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Physical activity monitoring
  • Nijmegen, Netherlands
    Department of Physiology
Nov 15, 2022

Hypercholesterolemia, CKD Stage 5, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Rome (Evolocumab, Ezetimibe,

Recruiting
  • Hypercholesterolemia
  • +2 more
  • Rome, Italy
    Policlinico Casilino
Dec 13, 2020

Coronary Artery Disease Trial in Boston (Rosuvastatin, Colchicine)

Not yet recruiting
  • Coronary Artery Disease
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 28, 2023

Hypercholesterolaemia Trial (MK-0616)

Not yet recruiting
  • Hypercholesterolaemia
  • (no location specified)
Jul 12, 2023

Chronic Kidney Diseases Trial in Bandung (Aerobic Exercise)

Recruiting
  • Chronic Kidney Diseases
  • Aerobic Exercise
  • Bandung, West Java, Indonesia
    Al Ihsan Hospital
Nov 13, 2023

Dialysis Adequacy in Nutritional Status in Hemodialysis Patients

Not yet recruiting
  • Dialysis Adequacy
  • Hemodialysis machine
  • (no location specified)
Oct 25, 2023

Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)

Recruiting
  • Atherosclerotic Cardiovascular Disease
  • Little Rock, Arkansas
  • +43 more
Jan 20, 2023

Sarcopenia Trial in Daejeon (exercise and nutritional support)

Not yet recruiting
  • Sarcopenia
  • exercise and nutritional support
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
May 30, 2023

Kidney Disease, End-Stage Trial in Kitchener (Qidni/D Hemodialysis System)

Recruiting
  • Kidney Disease, End-Stage
  • Qidni/D Hemodialysis System
  • Kitchener, Ontario, Canada
    Qidni Labs
Oct 10, 2023

Uremia Trial in Beijing (OCI-HF160, FX800HDF)

Completed
  • Uremia
  • OCI-HF160
  • FX800HDF
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Jun 1, 2023

Renal Dysfunction, Sepsis, Hemodialysis Trial in Jakarta Pusat (Ha-330 Hemoperfusion Filter Hemodialysis, Conventional

Recruiting
  • Renal Dysfunction
  • +2 more
  • Ha-330 Hemoperfusion Filter Hemodialysis
  • Conventional Hemodialysis
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo Hospital
Jul 2, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • high-intensity statin arm
  • low-intensity statin plus ezetimibe
  • (no location specified)
Oct 12, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral

Completed
  • Diabetes Mellitus, Type 2
  • +5 more
  • Atorvastatin 40 Mg Oral Tablet
  • Tunis, Tunisia
    University Hospital La Rabta
Apr 7, 2023

Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis

Not yet recruiting
  • Erythropoietin Resistant Anemia (EPO Resistant Anemia)
    • (no location specified)
    Sep 22, 2023

    Renal Dialysis Trial in Osmaniye (Reiki)

    Completed
    • Renal Dialysis
    • Reiki
    • Osmaniye, Turkey
      Osmaniye Korkut Ata University
    Apr 25, 2023

    Statins and Associated FACTorS in Coronary Artery Disease

    Recruiting
    • Coronary Heart Disease
    • blood and urine samples
    • Düsseldorf, Germany
      University-Hospital Düsseldorf Division of Cardiology, Pulmonary
    Apr 3, 2023

    Hemodialysis Trial (online hemodiafiltration, high flux hemodialysis, low flux hemodialysis)

    Completed
    • Hemodialysis
    • online hemodiafiltration
    • +2 more
    • (no location specified)
    Mar 5, 2023

    Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)

    Not yet recruiting
    • Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
    • Nanjing, Jiangsu, China
      the First affiliated hospital of Nanjing Medical University
    Feb 14, 2023

    End-Stage Kidney Disease Trial in United States (Hemodialysis twice weekly, Hemodialysis thrice weekly)

    Not yet recruiting
    • End-Stage Kidney Disease
    • Hemodialysis twice weekly
    • Hemodialysis thrice weekly
    • Irvine, California
    • +8 more
    Apr 25, 2023

    Hemodialysis Trial in Ankara (motivational interview)

    Enrolling by invitation
    • Hemodialysis
    • motivational interview
    • Ankara, Turkey
      Baskent University
    Jan 3, 2023